Beijing Hotgen Biotech Co Ltd (688068) — Capital Reinvestment Ratio
Beijing Hotgen Biotech Co Ltd (688068) has a Capital Reinvestment Ratio of 4.82x as of September 2025, meaning it reinvests 5% of its operating cash flow (CN¥3.05 Million) in capital expenditures (CN¥14.73 Million). See Beijing Hotgen Biotech Co Ltd (688068) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Beijing Hotgen Biotech Co Ltd Capital Reinvestment Ratio (2016–2022)
This chart tracks Beijing Hotgen Biotech Co Ltd's Capital Reinvestment Ratio across 7 annual periods.
Annual Capital Reinvestment Ratio for Beijing Hotgen Biotech Co Ltd (2016–2022)
Year-by-year Capital Reinvestment Ratio for Beijing Hotgen Biotech Co Ltd from 2016 to 2022. For live market cap and broader valuation context, see market cap of Beijing Hotgen Biotech Co Ltd.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2022 | 0.58x | CN¥978.75 Million | CN¥565.21 Million | ▲ +282.9% |
| 2021 | 0.15x | CN¥2.64 Billion | CN¥398.86 Million | ▼ -85.6% |
| 2020 | 1.05x | CN¥164.62 Million | CN¥172.27 Million | ▼ -77.1% |
| 2019 | 4.57x | CN¥19.37 Million | CN¥88.48 Million | ▲ +498.5% |
| 2018 | 0.76x | CN¥55.04 Million | CN¥42.00 Million | ▼ -74.6% |
| 2017 | 3.01x | CN¥22.95 Million | CN¥69.05 Million | ▲ +546.9% |
| 2016 | 0.47x | CN¥45.54 Million | CN¥21.18 Million | — |